Blog Posts

CSRxP ANALYSIS FINDS PHARMACEUTICAL INDUSTRY’S PROFIT MARGINS TEN TIMES GREATER THAN OTHER SECTORS OF DRUG SUPPLY CHAIN

Nov 20, 2024

Study Finds Big Pharma’s Price-Gouging and Patent Abuse Playbook Fuels Read More

BIG PHARMA WATCH: NOVO NORDISK LAUNCHES WEGOVY IN CHINA AT 85 PERCENT DISCOUNT COMPARED TO U.S.

Nov 19, 2024

Brand Name Manufacturers Continue to Charge U.S. Patients Highest Prices in Read More

BIG PHARMA WATCH: BRAND NAME DRUG MAKER TOUTS PATENT ABUSE PLAYBOOK THAT DELAYED ACCESS TO SAFER AND MORE EFFECTIVE TREATMENTS

Nov 15, 2024

Gilead CEO Touts Success of Company’s Patent Playbook on HIV Portfolio That Read More

BIG PHARMA EARNINGS WATCH: BRISTOL MYERS SQUIBB AND MERCK

Nov 11, 2024

Big Pharma Giants Conclude Latest Round of Earnings Reports Fueled by Read More

BIG PHARMA EARNINGS WATCH: NOVARTIS AND PFIZER

Nov 8, 2024

Big Pharma Giants Keep Beating Wall Street Expectations While Continuing to Read More

BIG PHARMA EARNINGS WATCH: ABBVIE, AMGEN AND GSK

Nov 7, 2024

Big Pharma Giants Rolling in Strong Earnings While Continuing to Hike Drug Read More

BIG PHARMA EARNINGS WATCH: ROCHE AND SANOFI

Oct 28, 2024

Big Pharma Giants Continue Reporting Expectation-Beating Q3 Earnings After Read More

SECOND OPINION: BIG PHARMA ONCE AGAIN TRIES TO DEFEND THE PATENT ABUSE STATUS QUO

Oct 23, 2024

Eli Lilly Opinion Column Reiterates Debunked Arguments on Innovation as Brand Read More

BIG PHARMA EARNINGS: JOHNSON & JOHNSON

Oct 17, 2024

Johnson & Johnson Reports Higher-Than-Expected Earnings Fueled by Price Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1 WEIGHT LOSS DRUG PRICES COULD COST MEDICARE $35 BILLION

Oct 10, 2024

CBO Confirms Cost of Blockbuster Obesity Drugs at Current Prices Would Read More

DOSE OF REALITY: BRAND NAME DRUG MAKERS INCREASINGLY UTILIZING ‘USE CODES’ TO GAME PATENT SYSTEM AND BLOCK COMPETITION

Sep 30, 2024

STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further Read More